Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease

Existing therapies for Parkinson’s disease (PD) are only symptomatic. As erythropoietin (EPO) is emerging for its benefits in neurodegenerative diseases, here, we test the protective effect driven by EPO in in vitro (SH-SY5Y cells challenged by MPP(+)) and in vivo (C57BL/6J mice administered with MP...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Antioxidants (Basel)
Κύριοι συγγραφείς: Rey, Federica, Ottolenghi, Sara, Giallongo, Toniella, Balsari, Alice, Martinelli, Carla, Rey, Robert, Allevi, Raffaele, Giulio, Anna Maria Di, Zuccotti, Gian Vincenzo, Mazzucchelli, Serena, Foresti, Roberta, Samaja, Michele, Carelli, Stephana
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2021
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830512/
https://ncbi.nlm.nih.gov/pubmed/33467745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10010121
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια